These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 331919)

  • 41. Clinical value of a combined anti-ischemic and anticholinergic substance with antidepressant properties.
    Brasseur R
    Angiology; 1978 Feb; 29(2):121-32. PubMed ID: 646177
    [No Abstract]   [Full Text] [Related]  

  • 42. Determination of plasma concentrations of cyclandelate and mandelic acid in patients with generalized atherosclerotic vasculopathy treated with oral cyclandelate.
    Forconi S; Cappelli R; Guerrini M; Volpi L; Frigerio C; Di Perri T
    J Int Med Res; 1990; 18(4):266-72. PubMed ID: 2227073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.
    Diener HC; Föh M; Iaccarino C; Wessely P; Isler H; Strenge H; Fischer M; Wedekind W; Taneri Z
    Cephalalgia; 1996 Oct; 16(6):441-7. PubMed ID: 8902255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrinolytic activity of oral cyclandelate in patients with generalized atherosclerotic vasculopathy: a double-blind study.
    Forconi S; Cappelli R; Guerrini M; Frigerio C; Messa GL; Furesi L
    J Int Med Res; 1990; 18(4):257-65. PubMed ID: 2121564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine.
    Mastrosimone F; Iaccarino C; de Caterina G
    J Med; 1992; 23(1):1-16. PubMed ID: 1573338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cyclandelate on perception, memory and cognition in a group of geriatric subjects.
    Aderman M; Giardina WJ; Koreniowski S
    J Am Geriatr Soc; 1972 Jun; 20(6):268-71. PubMed ID: 4555668
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effects of cyclandelate on the CNS--a double-blind, placebo-controlled study of healthy subjects].
    Dimpfel W; Netter P; Spüler M; Wedekind W
    Klin Wochenschr; 1991 May; 69(7):313-9. PubMed ID: 2067317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasodilators in senile dementias: a review of the literature.
    Yesavage JA; Tinklenberg JR; Hollister LE; Berger PA
    Arch Gen Psychiatry; 1979 Feb; 36(2):220-3. PubMed ID: 420543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclandelate in long standing cerebral arteriosclerosis.
    Rogers WF; Shaikh VA; Clark AN
    Gerontol Clin (Basel); 1970; 12(2):88-93. PubMed ID: 4987660
    [No Abstract]   [Full Text] [Related]  

  • 50. Modes and mechanisms of action of vasoactive drugs and especially of cyclandelate.
    Timmerman H
    Br J Clin Pract Suppl; 1984; 34():10-9. PubMed ID: 6430317
    [No Abstract]   [Full Text] [Related]  

  • 51. Cyclandelate: calcium modulation and clinical effects. Proceedings of a symposium. Helsinki, 14-15 November, 1986.
    Drugs; 1987; 33 Suppl 2():1-141. PubMed ID: 3622302
    [No Abstract]   [Full Text] [Related]  

  • 52. [Determination of the anti-anoxia capacity of drugs].
    Truchaud M
    Sem Hop Ther; 1977 Nov; 53(9):425-9. PubMed ID: 341317
    [No Abstract]   [Full Text] [Related]  

  • 53. A controlled clinical trial of amitriptyline added to perphenazine in the treatment of depressed schizophrenics [proceedings].
    Prusoff BA; Williams DH; Weissman MM; Astrachan BM
    Psychopharmacol Bull; 1979 Apr; 15(2):80-1. PubMed ID: 373008
    [No Abstract]   [Full Text] [Related]  

  • 54. Psychological test performance and sedation thresholds of elderly dements, depressives and depressives with incipient brain change.
    Davies G; Hamilton S; Hendrickson DE; Levy R; Post F
    Psychol Med; 1978 Feb; 8(1):103-9. PubMed ID: 635061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of cyclandelate on mental function in patients with arteriosclerotic brain disease.
    Fine EW; Lewis D; Villa-Landa I; Blakemore CB
    Br J Psychiatry; 1970 Aug; 117(537):157-61. PubMed ID: 4921174
    [No Abstract]   [Full Text] [Related]  

  • 56. A comparative clinical trial of mianserin (Norval) and amitriptyline in the treatment of depression in general practice.
    Murphy JE; Bridgman KM
    J Int Med Res; 1978; 6(3):199-206. PubMed ID: 348535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Metabolites of cyclandelate. Vasodilator action and inhibition of phosphodiesterase by metabolites of cyclandelate].
    Himber J; De Burlet G; Andermann G
    Ann Pharm Fr; 1987; 45(3):233-41. PubMed ID: 3434974
    [No Abstract]   [Full Text] [Related]  

  • 60. A placebo-controlled, double-blind trial of amitriptyline in bulimia.
    Mitchell JE; Groat R
    J Clin Psychopharmacol; 1984 Aug; 4(4):186-93. PubMed ID: 6381556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.